Opening https://www.globenewswire.com/news-release/2023/03/16/2628534/0/en/Abeona-Therapeutics-Announces-Acceptance-of-Abstract-on-EB-101-Phase-3-VIITAL-Study-Results-for-Oral-Presentation-at-International-Societies-for-Investigative-Dermatology-ISID-2023.html